# Prophylactic Central Lymph Node Dissection in Papillary Thyroid Microcarcinoma

> **NCT00795782** · PHASE3 · COMPLETED · sponsor: **Samsung Medical Center** · enrollment: 258 (actual)

## Conditions studied

- Thyroid Cancer

## Interventions

- **PROCEDURE:** Prophylactic central lymph node dissection

## Key facts

- **NCT ID:** NCT00795782
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2012-06
- **Final completion:** 2014-06
- **Target enrollment:** 258 (ACTUAL)
- **Last updated:** 2016-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00795782

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00795782, "Prophylactic Central Lymph Node Dissection in Papillary Thyroid Microcarcinoma". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00795782. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*